Anjaneyulu Sheri
Spring Bank Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
interferon and immune responses, Antibiotic Resistance in Bacteria, Antibiotics Pharmacokinetics and Efficacy, Cancer Research and Treatments, Hepatitis C virus research
Most-Cited Works
- → Antiviral Efficacy and Host Innate Immunity Associated with SB 9200 Treatment in the Woodchuck Model of Chronic Hepatitis B(2016)69 cited
- → Design, Synthesis, and Crystal Structures of 6-Alkylidene-2′-Substituted Penicillanic Acid Sulfones as Potent Inhibitors of Acinetobacter baumannii OXA-24 Carbapenemase(2010)66 cited
- → Rational Design of a β-Lactamase Inhibitor Achieved via Stabilization of the trans-Enamine Intermediate: 1.28 Å Crystal Structure of wt SHV-1 Complex with a Penam Sulfone(2006)54 cited
- → Sulbactam Forms Only Minimal Amounts of Irreversible Acrylate-Enzyme with SHV-1 β-Lactamase(2007)50 cited
- → Penicillin Sulfone Inhibitors of Class D β-Lactamases(2010)43 cited
- → Antiviral Efficacy and Host Immune Response Induction during Sequential Treatment with SB 9200 Followed by Entecavir in Woodchucks(2017)42 cited
- → SB 9200, a novel agonist of innate immunity, shows potent antiviral activity against resistant HCV variants(2017)29 cited
- → Preclinical studies of SB 11285, a novel STING agonist for immuno-oncology.(2017)25 cited
- → NOD2/RIG-I Activating Inarigivir Adjuvant Enhances the Efficacy of BCG Vaccine Against Tuberculosis in Mice(2020)23 cited
- → Design, Synthesis and Evaluation of Trisubstituted Thiazoles Targeting Plasmodium Falciparum Cysteine Proteases(2005)22 cited